Vitrolife AB (publ) appoints Carnegie as liquidity guarantor

Vitrolife has appointed Carnegie as the liquidity guarantor for its share, which is quoted on the O-list of the Stockholm Stock Exchange. The aim is to increase the liquidity of the share and to reduce the difference in price between the bid and ask price within the framework of the directions of the Stockholm Stock Exchange concerning liquidity guarantors. The undertaking to quote bid and ask prices in the order book begins as of October 31 2005. October 26, 2005 Kungsbacka, Sweden Vitrolife AB (publ) Questions should be addressed to: Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61. Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.

About Us

Vitrolife is an international medical device Group. The Fertility product area develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes. Vitrolife has approximately 330 employees and the company’s products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary and Denmark. The Vitrolife share is listed on NASDAQ OMX Stockholm, Mid Cap.

Subscribe

Documents & Links